Tandem Diabetes Care TNDM Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tandem Diabetes Care's unrealized gains on investments?
- Tandem Diabetes Care (TNDM) reported unrealized gains on investments of $470K in Q1 2026.
- How has Tandem Diabetes Care's unrealized gains on investments changed year-over-year?
- Tandem Diabetes Care's unrealized gains on investments decreased by 50.4% year-over-year, from $948K to $470K.
- What is the long-term trend for Tandem Diabetes Care's unrealized gains on investments?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's unrealized gains on investments has grown at a 62.1% compound annual growth rate (CAGR), from $86K to $963K.